Loading GILD charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading GILD comparable companies…
| GILDGilead Sciences, Inc.(opens in a new tab) | $213.86B | $30.99B | +6.5% | 79.9% | −7.6% | 6.90× | — |
|---|---|---|---|---|---|---|---|
| AMGNAmgen Inc.(opens in a new tab) | $253.56B | $38.09B | +9.1% | 69.5% | 30.0% | 6.66× | 29.0× |
| ABBVAbbVie Inc.(opens in a new tab) | $522.12B | $64.39B | +10.4% | 71.5% | 26.2% | 8.11× | 83.3× |
| VRTXVertex Pharmaceuticals Inc. / Ma(opens in a new tab) | $142.67B | $12.59B | +10.2% | 86.0% | 38.0% | 11.33× | 32.6× |
| REGNRegeneron Pharmaceuticals, Inc.(opens in a new tab) | $97.96B | $16.90B | +18.6% | 96.5% | 28.8% | 5.80× | 20.5× |
| Medianpeers, excl. GILD | $198.11B | $27.50B | +10.3% | 78.7% | 29.4% | 7.38× | 30.8× |